SRNE
Sorrento Therapeutics Inc

66,579
Loading...
Loading...
Sorrento Therapeutics, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It operates through the Sorrento Therapeutics and Scilex segments. The Sorrento Therapeutics segment consists of developing a portfolio of next generation treatments for three major therapeutic areas: cancer, infectious disease, and pain. The Scilex segment is largely organized around the company's non-opioid pain management operations. The company was founded by Henry H. Ji in 1989 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Sorrento Therapeutics Inc?
What is the 52-week high for Sorrento Therapeutics Inc?
What is the 52-week low for Sorrento Therapeutics Inc?
What is Sorrento Therapeutics Inc stock price today?
What was Sorrento Therapeutics Inc stock price yesterday?
What is the 50-day moving average of Sorrento Therapeutics Inc?

Latest SRNE News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.